1 year return (CAGR)
-50.00%
Neumora Therapeutics, Inc. Exchange (NASDAQ, USD)
NMRA
0.75
-0.02 (-2.98%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
140.92M
Price/Sales
-
Ent value
104.82M
Price/Book
3.17
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
17.29%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.78 |
| Daily high | 0.81 |
| Daily low | 0.73 |
| Daily Volume | 3.42M |
| All-time high | 19.76 |
| 1y analyst estimate | 6.14 |
| Beta | 2.78 |
| EPS (TTM) | -1.15 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 11 Mar 2026 |
Downside potential
Loading...
Downside potential data
| NMRA | S&P500 | |
| Current price drop from All-time high | -96.20% | -1.96% |
| Highest price drop | -96.89% | -56.47% |
| Date of highest drop | 14 May 2025 | 9 Mar 2009 |
| Avg drop from high | -66.01% | -10.68% |
| Avg time to new high | 94 days | 12 days |
| Max time to new high | 648 days | 1805 days |
News
